Search
Hypertension Paid Clinical Trials in Nebraska
A listing of 13 Hypertension clinical trials in Nebraska actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
13 - 13 of 13
The state of Nebraska currently has 13 active clinical trials seeking participants for Hypertension research studies. These trials are conducted in various cities, including Omaha, Lincoln, Kearney and Grand Island.
Featured Trial
High blood pressure (Hypertension) Clinical Study
Recruiting
A clinical study for people that suffer with High blood pressure (Hypertension)
Conditions:
High blood pressure (Hypertension)
Featured Trial
Stroke Clinical Study
Recruiting
A clinical study for people that suffer with Stroke
Conditions:
Stroke
Featured Trial
Chronic Kidney Disease (CKD) Clinical Study
Recruiting
A clinical study for people that suffer with Chronic Kidney Disease (CKD)
Conditions:
Chronic Kidney Disease (CKD)
Featured Trial
Cardiovascular Disease Clinical Study
Recruiting
A clinical study for people that suffer with Cardiovascular Disease
Conditions:
Cardiovascular Disease
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
Featured Trial
Lose Weight with Tirzepatide
Recruiting
Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to tirzepatide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
Semaglutide and Tirzepatide are advanced GLP-1 medications designed to support weight management and metabolic health. They work by targeting GLP-1 receptors in the body, helping regulate appetite, improve blood sugar control, and support sustainable weight loss.
Semaglutide and Tirzepatide are advanced GLP-1 medications designed to support weight management and metabolic health. They work by targeting GLP-1 receptors in the body, helping regulate appetite, improve blood sugar control, and support sustainable weight loss.
Conditions:
Overweight
Overweight and Obesity
Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial
Recruiting
Randomized trial comparing risk of hospital readmission and hypertensive complications between patients managed on Labetalol compared to Nifedipine.
Gender:
FEMALE
Ages:
19 years and above
Trial Updated:
04/10/2024
Locations: Nebraska Methodist Women's Hospital, Omaha, Nebraska
Conditions: Postpartum Preeclampsia, Hypertension in Pregnancy
13 - 13 of 13